Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T21:47:16.420Z.
Calculation as of: 2026-10-06T21:47:16.420Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6adff8253f4c85dc5eb0f5c76b7f284768243a99251a0912c87940a98678e1d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Lifeward Ltd.
Market Cap
$10.21M
Operating Cash Flow Yield
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD |
|---|---|---|
| Lifeward Ltd. (LFWD) | $10.21M | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A |
| Pluri Inc. (PLUR)vs › | $10.68M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
